SecBot SecBot
DEFA14A ·Filed Apr 27, 2026

AGL

agilon health, inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0001628280-26-027515
Proxy solicitation materials
Actionable Insight • Neutral

The supplement is administrative and does not change voting. The annual meeting is on June 2, 2026; no immediate trading action required. Monitor for any activist developments given the proxy fight context.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$27.90
T+0 close · Apr 27, 2026 · via day close
Latest settled
+259.39%
T+60 · $100.27
Vs SPY
+255.40%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 28 $27.90entry
  2. T+1 · 7mo ago −8.46%α −8.45% · $25.54
  3. T+5 · 7mo ago −3.44%α −5.13% · $26.94
  4. T+20 · 6mo ago +205.63%α +200.16% · $85.27
  5. T+60 · 4mo ago +259.39%α +255.40% · $100.27
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Agilon health filed a supplement to its proxy statement clarifying the appointment of Tim O'Rourke as CEO, President, and Class III Director. The supplement does not change any proposals or board recommendations for the June 2, 2026 annual meeting. This is a routine disclosure following the previously announced CEO appointment.

Key Financial Metrics

Meeting
2026-06-02

Key Facts

  • Tim O'Rourke appointed CEO and President, effective May 7, 2026.
  • O'Rourke also appointed as Class III Director, term expiring at 2027 annual meeting.
  • Compensation includes $850,000 base salary, $500,000 signing bonus, 120,000 RSUs, and 200,000 PSUs with stock price targets ($50, $100, $150).
  • Supplement does not alter proposals or board recommendations for the June 2, 2026 annual meeting.

Financial Impact

Executive compensation package: $850,000 base salary, $500,000 signing bonus, 120,000 RSUs, and 200,000 PSUs.

executive compensation

Risk Factors

  • Potential shareholder dissent if compensation is viewed as excessive given stock performance.
  • Proxy fight context may lead to heightened governance scrutiny.

Market Snapshot

Exchange
NYSE
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
8% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001628280-26-027515
Document: 0001628280-26-027515-index-headers.html0001628280-26-027515
Document: 0001628280-26-027515-index.html0001628280-26-027515
Document: 0001628280-26-027515.txt0001628280-26-027515

Track record

7 reports on AGL

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $117.09 Now $116.75 −0.29% settles Nov 23
  2. Nov 10, 20266d ago Institutional Cluster Neutral 3/10 Entry $113.52 Now $116.75 +2.85% settles Nov 17
  3. Nov 4, 202612d ago 8-K Bullish 7/10 Entry $113.77 to $110.30 Now $116.75 +2.62% ▼ −3.05% −6.34% vs SPY
  4. Apr 27, 202629w ago DEFA14A Neutral 2/10 Viewing Entry $27.90 to $26.94 Now $116.75 +318.46% ▼ −3.44% −5.13% vs SPY
  5. Apr 27, 202629w ago 8-K Neutral 4/10 Entry $27.90 to $26.94 Now $116.75 +318.46% ▼ −3.44% −5.13% vs SPY
  6. Feb 28, 202637w ago Institutional Cluster Bullish 6/10 Entry $15.40 to $15.00 Now $116.75 +658.12% ▼ −2.60% −1.42% vs SPY
  7. Feb 25, 202637w ago 8-K Mixed 6/10 Entry $0.5946 to $0.6645 Now $116.75 +19535.05% ▲ +11.76% +12.91% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 8h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 27, 2026